Acro Biomedical Co (Acro Biomedical Co) Cash And Cash Equivalents : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co Cash And Cash Equivalents?

Acro Biomedical Co's quarterly cash and cash equivalents declined from Dec. 2022 ($0.01 Mil) to Mar. 2023 ($0.00 Mil) but then increased from Mar. 2023 ($0.00 Mil) to Jun. 2023 ($0.00 Mil).

Acro Biomedical Co's annual cash and cash equivalents increased from Dec. 2020 ($0.02 Mil) to Dec. 2021 ($0.10 Mil) but then declined from Dec. 2021 ($0.10 Mil) to Dec. 2022 ($0.01 Mil).

Acro Biomedical Co Cash And Cash Equivalents Historical Data

The historical data trend for Acro Biomedical Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Cash And Cash Equivalents Chart

Acro Biomedical Co Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Dec20

Dec21

Dec22

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.02

0.10

0.01

Acro Biomedical Co Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Cash And Cash Equivalents	Get a 7-Day Free Trial															0.01	0.02	0.01	-	-

Acro Biomedical Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Acro Biomedical Co (OTCPK:ACBM) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Acro Biomedical Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Acro Biomedical Co (Acro Biomedical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038

Website

http://www.acrobiomedical.com

Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.

Executives

Pao-chi Chu

director, 10 percent owner, officer: CEO

2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines